Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • New Findings Elucidate Molecular Mechanisms of SLC29A3 Disorders

    University of Tokyo Researchers Explore Role of TLR7/8 Stress Responses in Histiocytosis

    The SLC29A3 gene in humans plays a critical role in lysosomal function, ensuring the effective recycling of waste in macrophages. It facilitates the transport of nucleosides, the breakdown products of RNA and DNA, from lysosomes to the cell's cytoplasm. Mutations that lead to the loss of function in this gene cause unusual nucleoside storage and a range of resulting conditions known as SLC29A3 disorders. Symptoms may include distinct skin patches, enlarged liver or spleen, hearing loss, or even type 1 diabetes. Among these, histiocytosis, marked by the build-up of mononuclear phagocytes (histiocytes) in various organs, has been particularly baffling to researchers.

    In a recent article in the Journal of Experimental Medicine, a research team from Japan offers clarity on the molecular mechanics of SLC29A3 disorders. They have identified that the malfunctions of the toll-like receptor (TLR) 7 and TLR8 in macrophages play a significant role in causing histiocytosis when SLC29A3 is not functioning. “We have now uncovered how TLR signaling, a key innate immune response pathway, contributes to histiocytosis in SLC29A3 disorders,” stated Prof. Kensuke Miyake of The Institute of Medical Science, University of Tokyo.

    When macrophages consume pathogens, the subsequent degradation of pathogenic RNA produces nucleosides, which are detected by TLR7 and TLR8. With mutations in SLC29A3 causing unusual nucleoside storage, the research team posited that the constant activation of TLR7 and TLR8 by these nucleosides might be a contributing factor to SLC29A3 disorders. Experiments with mice supported this theory. Prof. Takuma Shibata, the study's primary author, described the situation succinctly: “To put it simply, mutations in SLC29A3 lead to nucleoside accumulation in macrophages. These nucleosides activate TLR7 and TLR8, and this excessive TLR response leads to excess macrophage proliferation and accumulation.” Prof. Miyake added that this indicates SLC29A3's role in moderating the TLR7/8 response in the innate immune system's cells.

    This comprehensive study by Prof. Miyake and Associate Prof. Shibata provides valuable knowledge in innate immunology. With the identification of TLR7 and TLR8 as potential treatment targets for SLC29A3 disorders, the path to innovative therapeutic solutions seems promising. Prof. Miyake emphasizes that these findings can also enhance the understanding of other disorders tied to macrophage proliferation and build-up.

Latest Articles

Collapse

  • seqadmin
    Exploring the Dynamics of the Tumor Microenvironment
    by seqadmin




    The complexity of cancer is clearly demonstrated in the diverse ecosystem of the tumor microenvironment (TME). The TME is made up of numerous cell types and its development begins with the changes that happen during oncogenesis. “Genomic mutations, copy number changes, epigenetic alterations, and alternative gene expression occur to varying degrees within the affected tumor cells,” explained Andrea O’Hara, Ph.D., Strategic Technical Specialist at Azenta. “As...
    07-08-2024, 03:19 PM
  • seqadmin
    Exploring Human Diversity Through Large-Scale Omics
    by seqadmin


    In 2003, researchers from the Human Genome Project (HGP) announced the most comprehensive genome to date1. Although the genome wasn’t fully completed until nearly 20 years later2, numerous large-scale projects, such as the International HapMap Project and 1000 Genomes Project, continued the HGP's work, capturing extensive variation and genomic diversity within humans. Recently, newer initiatives have significantly increased in scale and expanded beyond genomics, offering a more detailed...
    06-25-2024, 06:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Yesterday, 05:49 AM
0 responses
10 views
0 likes
Last Post seqadmin  
Started by seqadmin, 07-15-2024, 06:53 AM
0 responses
20 views
0 likes
Last Post seqadmin  
Started by seqadmin, 07-10-2024, 07:30 AM
0 responses
36 views
0 likes
Last Post seqadmin  
Started by seqadmin, 07-03-2024, 09:45 AM
0 responses
204 views
0 likes
Last Post seqadmin  
Working...
X